Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 8th International Conference on Surgeons Dubai, UAE.

Day 2 :

Keynote Forum

Barış Cankaya

Marmara University Pendik Training Hospital, Turkey

Keynote: The role of the anesthesiologist in the perioperative period for patient safety
Conference Series SURGEONS CONF 2022 International Conference Keynote Speaker Barış Cankaya  photo
Biography:

Baris Canaya is an Anesthesiologist at Marmara University Pendik Training Hospital in Istanbul, Turkey. He has deep interest for resuscitation, acute critical illness, trauma anesthesia, pediatric congenital cardiovascular anesthesia and perioperative patient safety.

 

Abstract:

Aim: The aim of this abstract is to focus on the role of the anesthesiologist in perioperative period regarding patient safety.

Method: More than 100 studies published in 10 years are viewed to discuss on this topic selected from pubmed between years 2000 and 2019.

Discussion: It is not long before that patient safety during surgery had attention. Health providers have detailed monitoring tools with the help of developing technology, but on the other hand matching large data lead to confusion. Perioperative period is a dynamic process and it needs re-evaluation, fast interpretation, documentation and awareness. The quality of the interaction between the surgery and anesthesia teams makes a good impact on patients’ outcome. There has been adopted many terminologies as wrong-patient surgery, wrong-side surgery, wrong-level surgery. These are some of the reasons contributing to medical errors: Multiple surgeons’ involvement in the case, multiple interventions during a single surgery and patient characteristics as morbid obesity. There are some useful solutions: Culture of safety, medication safety, awareness for hospital acquired infections and solving communication errors.

Conclusion: Perioperative patient safety is a team work, collaboration and adopting new technologies will enhance perioperative safety of patients.

Keywords: patient safety, perioperative, anaesthesiologist

 

Keynote Forum

Rani Kanthan

University of Saskatchewan, Canada

Keynote: Mixed tumors of the colon and rectum: A review
Conference Series SURGEONS CONF 2022 International Conference Keynote Speaker Rani Kanthan  photo
Biography:

Rani Kanthan is a Consultant Anatomical Pathologist in the Department of Pathology and Laboratory Medicine at the University of Saskatchewan with a focused interest in surgical oncology including breast and gastrointestinal tract. She has published 130 peer reviewed manuscripts that are indexed in PubMed/Google Scholar and serves as an Editorial Board Member in various journals. She is an active Medical Educator and continues to participate and present at various national and international meetings with more than 145 conference abstract presentations to her credit.

 

Abstract:

Colorectal cancer is the third most commonly diagnosed malignancy and the fourth leading cause of cancer death in the world with a projected expected increase of the global burden of disease by 60%. Of these the majority up to 70% arise in the colon and 30% in the rectum. Though stage dependent, the overall survival rate is around 67% and this often relates to the usual adenocarcinoma encountered in the colon and rectum. Mixed tumors of the gastrointestinal tract that have an exocrine component-adenocarcinoma and neuroendocrine component are poorly understood lesions and therefore challenging for interdisciplinary therapy. Though they were known to exist since 1924 it was only officially endorsed by the WHO in 2000 who defined mixed exocrine-endocrine tumors consisting of both components with at least 30% representation of each component. This has been further refined in the 2010 WHO classification. The history and evolution of these tumors to its current state with proposed histogenesis will be discussed. The importance of expertise in gastrointestinal pathology for accurate recognition of these tumors and the use of ancillary techniques such as immunohistochemical stains will be addressed together with detailed relevant surgical pathology. Multidisciplinary management of these tumors is imperative for success and treatment strategies that include incorporating the use of cisplatin and etopsid in the management of these rare colorectal carcinomas will be deliberated.

 

Conference Series SURGEONS CONF 2022 International Conference Keynote Speaker Elena Orsenigo   photo
Biography:

Elena Orsenigo is a General Surgeon with more than 30 years of experience as well as broad medical experience. She has excellent bedside manner and patient communication skills developed through more than three decades of combined schooling and teaching experience. She is the Chief of Minimally Invasive Surgery at San Raffaele Hospital, lead and assist in a variety of surgical procedures to address injuries, inflammatory and oncological diseases, communicate with patients and other medical professionals to create a treatment plan that includes preoperative preparations, surgical protocols and postoperative care and also prepare reports and other forms of documentation to keep patient charts updated around the clock during pre- and post-surgical hospital stays. She is also a Professor of Surgery and author of 88 paper published on PubMed.

 

Abstract:

A diagnosis of cancer following a complicated presentation is associated with poorer clinical and patient-reported outcomes. These inferior outcomes include the less-frequent use of treatments with a curative intent, well-established associations between emergency or urgent presentation and inferior survival and worse quality of life and patient experience than those diagnosed with cancer through other routes. Outlet obstruction, perforation and overt bleeding are ominous complications of gastric cancer. Gastric outlet obstruction was described by Sir, James Walton as “The stomach you can hear, the stomach you can feel and the stomach you can see”. Gastric outlet obstruction implies complete or incomplete obstruction of the distal stomach, pylorus or proximal duodenum. Once a mechanical obstruction is confirmed, the problem is to differentiate between benign and malignant processes because definitive treatment is based on recognition of the specific underlying cause. The most common cause of gastric outlet obstruction in adults is gastric cancer (63%) and the remaining 37% are due to benign disease. Surgeons should have to take into consideration that repeated vomiting in these patients causes nutritional deficiencies and occurs with marked dilatation and edematous thickening of the gastric wall. Nutritional deficiency has been regarded as a significant risk factor for postoperative complications in major abdominal surgery. Gastric carcinoma with pyloric stenosis, the main source of malignant gastric outlet obstruction, is usually far advanced and the significance of surgical treatment for such conditions has been given little attention in the literature. Perforated gastric is rare, accounting for 0.3-3% of gastric cancer cases. Only one third of cases of perforated gastric cancer are diagnosed preoperatively. Gastric cancer bleeding accounts for 58% of the bleeding cases resulting from upper gastrointestinal malignancies. The effects of obstruction, perforation and overt bleeding and the possible simultaneous effects of these conditions on the outcome of gastric carcinoma are difficult to determine because the definitions of these conditions used in previous studies were either imprecise or not stated. Given this lack of clarity about the entities of outlet obstruction, perforation and overt bleeding in gastric cancer it is not surprising that the impact of these conditions on outcome remains unclear. The goal is define the impact of complicated gastric cancer on the clinical outcome of the patients.